These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22227462)

  • 21. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 22. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rho GTPases as therapeutic targets in cancer and other human diseases].
    Lorenzano Menna P; Cardama GA; Comin MJ; Alonso DF; Gómez DE
    Medicina (B Aires); 2010; 70(6):555-64. PubMed ID: 21163747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-protein interactions as targets for antiviral chemotherapy.
    Loregian A; Marsden HS; Palù G
    Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral applications of Toll-like receptor agonists.
    Horscroft NJ; Pryde DC; Bright H
    J Antimicrob Chemother; 2012 Apr; 67(4):789-801. PubMed ID: 22258929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting survivin in cancer: the cell-signalling perspective.
    Kanwar JR; Kamalapuram SK; Kanwar RK
    Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-Gamma: Treatment Horizons.
    Khryanin AA; Reshetinikov OV
    Antibiot Khimioter; 2016 Aug; 61():35-40. PubMed ID: 29874451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vitamins and infectious diseases].
    Tassinari G
    Minerva Med; 1973 Apr; 64(29):1551-8. PubMed ID: 4740298
    [No Abstract]   [Full Text] [Related]  

  • 30. The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.
    Wanka L; Iqbal K; Schreiner PR
    Chem Rev; 2013 May; 113(5):3516-604. PubMed ID: 23432396
    [No Abstract]   [Full Text] [Related]  

  • 31. Repositioning of drugs using open-access data portal DTome: A test case with probenecid (Review).
    Ahmed MU; Bennett DJ; Hsieh TC; Doonan BB; Ahmed S; Wu JM
    Int J Mol Med; 2016 Jan; 37(1):3-10. PubMed ID: 26572802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon: a perspective.
    Weissman RM; Droller MJ
    Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
    [No Abstract]   [Full Text] [Related]  

  • 33. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials.
    Colabufo NA; Berardi F; Cantore M; Contino M; Inglese C; Niso M; Perrone R
    J Med Chem; 2010 Mar; 53(5):1883-97. PubMed ID: 19924994
    [No Abstract]   [Full Text] [Related]  

  • 35. New avenues to target Wnt/β-catenin signaling.
    Verkaar F; Zaman GJ
    Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spirocyclic nucleosides in medicinal chemistry: an overview.
    Soengas RG; Silva S
    Mini Rev Med Chem; 2012 Dec; 12(14):1485-96. PubMed ID: 22827180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural systems pharmacology: the role of 3D structures in next-generation drug development.
    Duran-Frigola M; Mosca R; Aloy P
    Chem Biol; 2013 May; 20(5):674-84. PubMed ID: 23706634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design and development of covalent protein-protein interaction inhibitors for cancer treatment.
    Cheng SS; Yang GJ; Wang W; Leung CH; Ma DL
    J Hematol Oncol; 2020 Mar; 13(1):26. PubMed ID: 32228680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
    Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
    Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.
    Wolber G; Langer T
    J Chem Inf Model; 2005; 45(1):160-9. PubMed ID: 15667141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.